Skip to main content

Table 5 Regression results adjusted for variations at health facility level and seasonality, Jan 2016–Mar 2017

From: Effects and factors associated with indoor residual spraying with Actellic 300 CS on malaria morbidity in Lira District, Northern Uganda

Time in months in relation to IRS with Actellic 300 CS Adjusted percentage point changes (pp) in confirmed Malaria 95% confidence interval P-value
Percentage point changes before IRS intervention
 Jan 2016 Ref.    
 Feb 2016 − 0.05 − 0.58 0.47 0.836
 March 2016 − 1.03 − 1.60 − 0.45 < 0.001
 April 2016 − 0.35 − 0.83 0.13 0.153
 May 2016 0.66 0.14 1.17 0.012
 June 2016 0.97 0.53 1.40 < 0.001
 July 2016 0.71 0.27 1.16 0.002
Percentage point changes after IRS intervention
 August (spray month) Ref    
 Sept (1 months after IRS) − 0.07 − 0.98 0.84 0.878
 Oct (2 month after IRS) − 0.18 − 1.09 0.74 0.702
 Nov (3 month after IRS) − 0.13 − 1.04 0.78 0.781
 Dec (4 month after IRS) − 0.39 − 0.85 0.05 0.085
 Jan 17 (5 month after IRS) − 0.60 − 1.08 − 0.12 0.015
 Feb 17 (6 month after IRS) − 1.19 − 1.79 − 0.60 < 0.001
 Mar 17 (7 month after IRS) − 1.97 − 2.10 0.12 0.081
  1. Adj. pp = percentage point change in outpatient attendance due to confirmed Malaria, adjusted for seasonality and variation at health facility level